Search for: "Wyeth, Inc."
Results 421 - 440
of 877
Sorted by Relevance
|
Sort by Date
29 Dec 2011, 6:53 am
Wyeth LLC, 131 S. [read post]
2 Jul 2014, 4:30 am
Wyeth Ayerst Pharmaceuticals, Inc., 2014 U.S. [read post]
6 Sep 2013, 8:10 am
Wyeth, No. 12-6078, 2013 U.S. [read post]
10 Jul 2013, 2:57 pm
Wyeth Pharmaceuticals, 797 F. [read post]
28 Nov 2012, 5:00 am
The Hain Celestial Group, Inc., 2012 U.S. [read post]
25 Jun 2015, 5:00 am
Wyeth, 705 S.E.2d 828 (W. [read post]
26 Mar 2013, 9:35 am
Caterpillar, Inc. 111 F.2d 1039 (3d Cir. 1997). [read post]
2 Jul 2009, 5:18 am
Wyeth, 894 A.2d 141, 145, 149-50 (Pa. [read post]
29 Sep 2015, 8:41 am
Wyeth Pharmaceuticals, Inc. [read post]
1 Jul 2009, 3:50 am
Dept. of the Army and Dept. of Defense of the U.S., 548 Pa. 178, 696 A.2d 137, 145-46 (1997) (requiring the prescribed monitoring regime is reasonably necessary according to contemporary scientific principles); Wyeth, Inc. v. [read post]
29 May 2014, 5:00 am
Wyeth-Ayerst Laboratories, 1994 WL 532091, at *1 (E.D. [read post]
21 Jun 2012, 11:46 am
Wyeth, on behalf of Shulton, Inc. [read post]
23 May 2008, 10:17 pm
Philip Morris USA, Inc., 142 P.3d 1079 (Or. [read post]
25 Mar 2012, 7:16 pm
Pliva, Inc. v. [read post]
10 Dec 2010, 2:23 pm
The Court consolidated three separate cases on the issue, to be heard in one hour of oral argument: PLIVA Inc. v. [read post]
23 Feb 2011, 9:20 am
Aventis Pasteur, Inc., 2011 Pa. [read post]
23 Oct 2008, 10:31 am
" In addition, ImClone System Inc.'s Erbitux (cetuximab) "got a warning for its ties to cardiopulmonary arrest, while Genentech Inc.'s Herceptin (trastuzumab) was linked to infusion-site reactions and lung toxicity. [read post]
3 Jul 2008, 7:26 pm
Wyeth-Ayerst Laboratories, Division of Amer [read post]
25 Jun 2012, 1:57 pm
Wyeth, Inc. [read post]
1 Mar 2010, 2:49 am
USPTO Rule Making Authority - a panel discussion on recent court challenges to the USPTO's rulemaking and interpreting power, including the Cooper Technologies, Tafas, and Wyeth cases featuring Professor James Speta of the Northwestern University School of Law; Patent Docs author Donald Zuhn, a Partner at McDonnell Boehnen Hulbert & Berghoff LLP; Nicholas Zovko of Knobbe Martens Olson & Bear LLP; and Professor Jonathan Masur of the University of Chicago Law School; and •… [read post]
